Trade Champions Oncology, Inc. - CSBR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.17 |
| Open | 4.05 |
| 1-Year Change | -33.39% |
| Day's Range | 3.38 - 4.41 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | 3.74 | -0.31 | -7.65% | 4.05 | 4.49 | 3.38 |
| Sep 9, 2024 | 4.17 | 0.15 | 3.73% | 4.02 | 4.22 | 4.02 |
| Sep 6, 2024 | 4.24 | 0.22 | 5.47% | 4.02 | 4.24 | 4.02 |
| Sep 5, 2024 | 4.13 | -0.11 | -2.59% | 4.24 | 4.24 | 4.07 |
| Sep 4, 2024 | 4.13 | 0.11 | 2.74% | 4.02 | 4.13 | 4.02 |
| Sep 3, 2024 | 4.02 | -0.12 | -2.90% | 4.14 | 4.31 | 4.02 |
| Aug 30, 2024 | 3.87 | -0.37 | -8.73% | 4.24 | 4.24 | 3.86 |
| Aug 29, 2024 | 3.95 | -0.30 | -7.06% | 4.25 | 4.44 | 3.81 |
| Aug 28, 2024 | 4.25 | -0.06 | -1.39% | 4.31 | 4.50 | 4.04 |
| Aug 27, 2024 | 4.45 | -0.06 | -1.33% | 4.51 | 4.51 | 4.21 |
| Aug 26, 2024 | 4.49 | -0.09 | -1.97% | 4.58 | 4.60 | 4.40 |
| Aug 23, 2024 | 4.57 | 0.37 | 8.81% | 4.20 | 4.94 | 4.20 |
| Aug 22, 2024 | 4.40 | 0.27 | 6.54% | 4.13 | 4.40 | 4.13 |
| Aug 21, 2024 | 4.30 | 0.34 | 8.59% | 3.96 | 4.32 | 3.80 |
| Aug 20, 2024 | 4.35 | 0.06 | 1.40% | 4.29 | 4.35 | 4.29 |
| Aug 19, 2024 | 4.35 | -0.04 | -0.91% | 4.39 | 4.40 | 4.07 |
| Aug 16, 2024 | 4.46 | 0.07 | 1.59% | 4.39 | 4.46 | 4.38 |
| Aug 15, 2024 | 4.49 | 0.03 | 0.67% | 4.46 | 4.49 | 4.39 |
| Aug 14, 2024 | 4.54 | 0.08 | 1.79% | 4.46 | 4.54 | 4.46 |
| Aug 13, 2024 | 4.46 | 0.00 | 0.00% | 4.46 | 4.46 | 4.46 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Champions Oncology, Inc. Company profile
About Champions Oncology Inc
Champions Oncology, Inc. is engaged in creating transformative technology solutions to be utilized in oncology drug discovery and development. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.
Financial summary
BRIEF: For the nine months ended 31 January 2022, Champions Oncology Inc revenues increased 19% to $36.2M. Net income decreased 14% to $892K. Revenues reflect Pharmacology services segment increase of 66% to $34.5M, Other segment increase from $101K to $1.7M. Net income was offset by research and development increase of 32% to $6.8M (expense), general and administratiojn increase of 32% to $5.9M (expense).
Equity composition
Common Stock $.001 Par, 01/11, 50M auth., 36,853,000 issd. less 1,236,000 shs. in Treas. @ $292K. Insiders & strategic holders own 64.79%. Public Offering 9/85, 40M Units (1 sh. com. + 3 warrants) @ $.01 by the Company. 02/07, Name changedfrom Champions Sports Inc.08/15, 1-for-12 Reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
Suite 619
855 N. Wolfe Street
BALTIMORE
MARYLAND 21205
US
News
Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com